snip (token reduction for shell output) — via Homebrew; non-fatal if unavailable uv + memsearch (local vector database for session memory) — non-fatal if install fails bun + ralph (open-ralph-wiggum ...

Many proteins in the body are known to cause disease but remain stubbornly out of reach for the traditional ways of drugging a target. Parabilis Medicines has developed a new therapeutic modality to ...

The Exile are among America’s mere handful of deathrock buzz bands. After four years of climbing the live ladder and ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...

"Might hold insights relevant for healthy aging in humans." ...

China establishes VLEO industry alliance as satellites demonstrate sustained low-orbit operations China has established a ...

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the sector’s history. The cancer biotech, formerly known as FogPharma, has offered 33.5 million ...

Parabilis has shattered Kailera’s recently-set IPO high, raising a record-breaking $670 million. The Nasdaq debut surpasses even Parabilis’ expectations, with the peptide biotech announcing plans ...